Imidazole and compound L8027 (selective inhibitors of thromboxane synthase) produced parallel inhibition ofmalonaldehyde and thromboxane B2 secretion induced by collagen or thrombin in gel-filtered suspensions of human platelets. Comparing the effects of these inhibitors and aspirin on secretion of granule constituents indicated that platelet degranulation depends mainly on thromboxane production; prostaglandin endoperoxides contributed little.
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Platelet-aggregation responses associated with the secretion of platelet granule constituents (secondary aggregation) are modulated by prostaglandins and thromboxane A2 (for review see . Agents that induce secondary aggregation activate a phospholipase A2, which liberates from membrane phospholipids arachidonic acid, the major substrate for the platelet enzyme cascade known as prostaglandin synthase (Blackwell et al., 1977) . Arachidonic acid is then metabolized by fatty acid cyclo-oxygenase (EC 1.14.99.1) to prostaglandin endoperoxides (prostaglandins G2 and H2), which are unstable in aqueous media and are rapidly converted into prostaglandins D2, E2 and F2a, into thromboxane A2, and into malonaldehyde plus 12-L-hydroxyheptadeca-5,8,10-trienoic acid (Willis et al., 1974; Hamberg et al., 1975) . Prostaglandin endoperoxides and thromboxane A2 are powerful inducers of platelet aggregation and secretion, but the relative importance of these endogenously produced labile substances in mediating platelet responses to other stimuli is under debate (Hamberg et al., 1975; Needleman et al., 1977; Fitzpatrick & Gorman, 1978) .
The involvement of arachidonate metabolites in platelet function has led to the search for a convenient indicator of platelet prostaglandin synthase activity. Malonaldehyde formation can be readily assayed colorimetrically (Stuart et al., 1975; Macfarlane et al., 1977) or fluorimetrically (McMillan et al., 1977) , but a major disadvantage of using this product as an assay for prostaglandin biosynthesis is that the pathway of malonaldehyde formation from arachidonic acid has not been elucidated. Diczfalusy et al. (1977) isolated and purified thromboxane synthase from human platelet homogenates and reported that this enzyme was responsible for the formation of malonaldehyde (and hydroxyheptadecatrienoic acid) as well as thromVol. 176 boxane B2. There is, however, no evidence for this in intact cells. We have now investigated malonaldehyde and thromboxane B2 production by gelfiltered platelets and studied the effects of selective inhibitors of fatty acid cyclo-oxygenase and of thromboxane synthase. In addition, by comparing the effects of these selective inhibitors on platelet degranulation responses, we have estimated the relative importance of prostaglandin endoperoxides and thromboxane A2 in modulating platelet secretion.
Methods
Human blood was obtained by antecubital venepuncture from volunteers who had ingested no drugs for at least 7 days. One vol. of trisodium citrate (0.13 M) was added to 9 vol. of blood, and platelet-rich plasma was prepared by centrifugation (lSOOg at 20°C for 1 min). Plasma-free suspensions of platelets in calcium-free Tyrode buffer were prepared by gel filtration with Sepharose 2B (Salzman et al., 1976) . Platelet aggregation was measured photometrically (Born, 1962) in 0.1 ml or 0.15ml samples (Gordon & Drummond, 1974 Platelet aggregation, in 0.1 ml samples of gel-filtered platelets, was terminated by the addition of 0.4ml of ice-cold 0.4% (w/v) EDTA in iso-osmotic saline and rapid centrifugation (14700g for 30s). Subsamples of cell-free supernatant were removed for fluorimetric measurement of lysosomal enzyme release (Gordon, 1975) (MacIntyre et aL, 1978) .
For measurement of arachidonate metabolites platelet aggregation in 0.15ml samples of gelfiltered platelets was terminated by the addition of 0.45ml of 100% ethanol and rapid centrifugation. Subsamples ofthe cell-free supernatant were removed for fluorimetric measurement of malonaldehyde (McMillan et al., 1977) or for radioimmunoassay of thromboxane B2 (Sors et al., 1978) .
Materials
Bovine thrombin and tendon collagen were obtained from Sigma (London Results and Discussion Fig. 1 shows the effect of compound L8027 and imidazole on malonaldehyde and thromboxane B2 production by gel-filtered platelets stimulated with thrombin and collagen. Both drugs produced parallel inhibition of malonaldehyde and thromboxane B2 synthesis, whether induced by thrombin or collagen, although the absolute potencies of the drugs differed markedly. Inhibition of fatty acid cyclo-oxygenase, the initial enzyme of the prostaglandin synthesis pathway, blocks the formation of all products derived from prostaglandin endoperoxides, and therefore cyclo-oxygenase inhibitors such as aspirin (Rome et al., 1976) produce the same pattern of inhibition as that shown in Fig. 1 . However, at the concentrations used in the present study, compound L8027 and imidazole act selectively on thromboxane synthase and do not affect fatty acid cyclo-oxygenase (Gryglewski et al., 1977; Needleman et al., 1977) . These results therefore indicate that in whole platelets, as in microsomal preparations, malonaldehyde and thromboxane B2 are formed by the same enzyme.
Although the studies cited above showed that compound L8027 and imidazole do not act on cyclooxygenase, we wished to confirm this under our experimental conditions by establishing that these drugs were not acting like aspirin. Therefore, the were measured in gelfiltered suspensions of human platelets as described in the text. Platelets were stimulated by collagen (20pg/ml). When present, drugs were added 2 min before collagen. Values are means ± S.E.M. (n = 4), expressed as a percentage of control responses (i.e. with no drug present). In control samples, 1. (Table 1) . This is consistent with blockade of thromboxane synthase by compound L8027 and imidazole and blockade of cyclo-oxygenase by aspirin, because cyclo-oxygenase inhibition prevents the formation of both types of endogenous pro-secretory agent (prostaglandin endoperoxides and thromboxane A2), whereas thromboxane synthase inhibition does not affect prostaglandin endoperoxide formation. By comparing the inhibition of platelet secretion by cyclo-oxygenase and thromboxane synthase inhibitors, it is possible to estimate the relative importance of individual arachidonate metabolites. Compound L8027 produced approx. 60 % inhibition of [14C]serotonin and lysosomal enzyme secretion, which presumably represents the component of the secretory response mediated by thromboxane A2. Aspirin inhibited secretion by approx. 80%. The additional inhibition by aspirin presumably represents the maximal contribution of the prostaglandin endoperoxides to the degranulation processes.
The results of the present study support the concept that, in intact platelets, malonaldehyde and thromboxane B2 are both derived via thromboxane synthase. Moreover we have demonstrated that both prostaglandin endoperoxides and thromboxane A2 contribute to platelet secretion induced by collagen and that secretion dependent on thromboxane A2 generation exceeds that due to prostaglandin endoperoxide generation. Malonaldehyde production has been proposed as a suitable marker for platelet prostaglandin synthase activity (Stuart et al., 1975; , but our present results indicate that this premise is not justified: platelet malonaldehyde production apparently reflects thromboxane synthase activity accurately, but is not an adequate indicator of the cyclo-oxygenase that is the initial step in the platelet prostaglandin-synthetic pathway. It remains to be determined whether malonaldehyde is formed from thromboxane synthase in other cells, most of which synthesize little thromboxane, but much more prostaglandins, when stimulated, compared with platelets.
